Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Olaia Aurtenetxe SáezAurora Navajas
Gynecologic and Obstetric Investigation
Polina AdvolodkinaAlan N Gordon
The Journal of Clinical Endocrinology and Metabolism
Leonie J M HerrmannStefanie Hahner
Archives of Pathology & Laboratory Medicine
Sameer S TalwalkarLynne V Abruzzo
Orphanet Journal of Rare Diseases
Amanda G SilvaMaria Isabel Achatz